The $50M termination fee provides a near-term cash infusion equal to market cap, likely supporting the stock price. However, the loss of the merger leaves Rallybio without a clear strategic direction; monitor for potential new deals or return of capital.
Price Chart
Executive Summary
Candid Therapeutics terminated its merger agreement with Rallybio to enter a deal with UCB S.A. Rallybio receives a $50M termination fee (~100% of market cap) plus $375k expense reimbursement, providing a cash windfall but leaving Rallybio without a merger partner.
Key Facts
- Candid terminated the merger agreement with Rallybio on May 3, 2026, to pursue a Permitted Alternative Agreement with UCB S.A.
- Rallybio is entitled to a $50,000,000 Parent Termination Fee and $375,000 expense reimbursement, to be paid by May 4, 2026.
- Rallybio will withdraw its Form S-4 registration statement filed in connection with the merger.
Financial Impact
Rallybio receives $50.375M cash (termination fee + expenses), nearly equal to its $50M market cap.
Risk Factors
- No replacement acquisition or partnership in sight.
- Cash burn rate may deplete the fee if not deployed effectively.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-202601 |
| Document: d19625dex21.htm | 0001193125-26-202601 |
| Document: 0001193125-26-202601-index-headers.html | 0001193125-26-202601 |
| Document: 0001193125-26-202601-index.html | 0001193125-26-202601 |
| Document: 0001193125-26-202601.txt | 0001193125-26-202601 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | EFFECT | $16.28 | awaiting T+60 | — | $16.65 (+2.27%) |
Oct 14, 2026 11d ago | S-4/A | $16.78 | awaiting T+60 | — | $16.65 (−0.75%) |
Jul 15, 2026 14w ago | S-4 | $15.96 $17.02 | ▲ +6.64% | ▲ +2.93% | $16.65 (+4.32%) |
Jun 1, 2026 21w ago | 425 | $16.87 $16.89 | ▲ +0.09% | ▼ −1.14% | $16.65 (−1.30%) |
Jun 1, 2026 21w ago | 8-K | $16.87 $16.89 | ▲ +0.09% | ▼ −1.14% | $16.65 (−1.30%) |
May 4, 2026 25w ago | 8-K | $14.12 $15.96 | ▲ +13.03% | ▲ +11.17% | $16.65 (+17.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers